COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 2888: Articles 28871-28880  | Next

"No test is better than a bad test": Impact of diagnostic uncertainty in mass testing on the spread of Covid-19
Gray, N., Calleja, D., Wimbush, A., Miralles-Dolz, E., Gray, A., De-Angelis, M., Derrer-Merk, E., Oparaji, B. U., Stepanov, V., Clearkin, L., Ferson, S.
10.1101/2020.04.16.20067884 — Posted: 2020-04-22
The Contribution of Age Structure to the Number of Deaths from Covid-19 in the UK by Geographical Units
Kulu, H., Dorey, P.
10.1101/2020.04.16.20067991 — Posted: 2020-04-22
Utah-Stanford Ventilator (Vent4US): Developing a rapidlyscalable ventilator for COVID-19 patients with ARDS
Li, H., Li, E., Krishnamurthy, D., Kolbay, P., Chacin, B., Hoehne, S., Cybulski, J., Brewer, L., Petelenz, T., Orr, J., Sakata, D., Clardy, T., Kuck, K., Prakash, M.
10.1101/2020.04.18.20070367 — Posted: 2020-04-22 Discussion: Offsite
LONG-TERM CLINICAL OUTCOMES IN SURVIVORS OF CORONAVIRUS OUTBREAKS AFTER HOSPITALISATION OR ICU ADMISSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF FOLLOW-UP STUDIES
Ahmed, H., Patel, K., Greenwood, D., Halpin, S., Lewthwaite, P., Salawu, A., Eyre, L., Breen, A., O'Connor, R., Jones, A., Sivan, M.
10.1101/2020.04.16.20067975 — Posted: 2020-04-22 Discussion: Onsite
Modeling projections for COVID-19 pandemic by combining epidemiological, statistical, and neural network approaches
Uhlig, S., Nichani, K., Uhlig, C., Simon, K.
10.1101/2020.04.17.20059535 — Posted: 2020-04-22
How many are at increased risk of severe COVID-19 disease? Rapid global, regional and national estimates for 2020
Clark, A., Jit, M., Warren-Gash, C., Guthrie, B., Wang, H. H., Mercer, S. W., Sanderson, C., McKee, M., Troeger, C., Ong, K. I., Checchi, F., Perel, P., Joseph, S., Gibbs, H. P., Banerjee, A., LSHTM CMMID COVID-19 working group, , Eggo, R. M.
10.1101/2020.04.18.20064774 — Posted: 2020-04-22 Discussion: Onsite | Offsite
Controlled Avalanche: A Regulated Voluntary Exposure Approach for Addressing Covid19
Klement, E., Klement, A., Chinitz, D., Harel, A., Fattal, E., Klausner, Z.
10.1101/2020.04.12.20062687 — Posted: 2020-04-22
The Enlightenment of mainland China's epidemic situation to the world through the intrinsic growth rule of infected and cured cases with COVID-19
Han, C., Liu, Y., Tang, J., Zhu, Y., Yang, S.
10.1101/2020.04.16.20067454 — Posted: 2020-04-22
Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy
Carsana, L., Sonzogni, A., Nasr, A., Rossi, R., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., Galli, M., Catena, E., Tosoni, A., Gianatti, A., Nebuloni, M.
10.1101/2020.04.19.20054262 — Posted: 2020-04-22 Discussion: Onsite | Offsite
Interleukin-6 blockade for severe COVID-19
ROUMIER, M., PAULE, R., GROH, M., VALLEE, A., ACKERMANN, F.
10.1101/2020.04.20.20061861 — Posted: 2020-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).